- Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?
-
Bogani G, Raspagliesi F
- KMID: 2440519
- J Gynecol Oncol.
- 2019 May;30(3):e68.
- doi: 10.3802/jgo.2019.30.e68
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology
-
Bogani G, Leone Roberti Maggiore U, Raspagliesi F
- KMID: 2417471
- J Gynecol Oncol.
- 2018 Sep;29(5):e84.
- doi: 10.3802/jgo.2018.29.e84
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Embryos need a cozy house
-
Martinelli F, Filippi F, Raspagliesi F, Somigliana E
- KMID: 2363327
- J Gynecol Oncol.
- 2016 May;27(3):e34.
- doi: 10.3802/jgo.2016.27.e34
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility-sparing surgery in high-risk ovarian cancer
-
Ditto A, Bogani G, Martinelli F, Raspagliesi F
- KMID: 2345927
- J Gynecol Oncol.
- 2015 Oct;26(4):350-351.
- doi: 10.3802/jgo.2015.26.4.350
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Sentinel lymph node detection in endometrial cancer: does injection site make a difference?
-
Bogani G, Martinelli F, Ditto A, Signorelli M, Chiappa V, Recalcati , Lorusso D, Raspagliesi F
- KMID: 2360253
- J Gynecol Oncol.
- 2016 Mar;27(2):e23.
- doi: 10.3802/jgo.2016.27.e23
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio
-
Bogani G, Chiappa V, Ditto A, Martinelli F, Signorelli M, Lorusso D, Raspagliesi F
- KMID: 2374239
- J Gynecol Oncol.
- 2016 Jul;27(4):e37.
- doi: 10.3802/jgo.2016.27.e37
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva
-
Raspagliesi F, Zanaboni F, Martinelli F, Scasso S, Laufer J, Ditto A
- KMID: 1811184
- J Gynecol Oncol.
- 2014 Jan;25(1):22-29.
- doi: 10.3802/jgo.2014.25.1.22
OBJECTIVE: The therapeutic outcomes of patients with advanced vulvar cancer are poor. Multi-modality treatments including concurrent chemoradiation or different regimens of neoadjuvant chemotherapy (NACT), and surgery have been explored to... -
- CITED
-
- Close
- SHARE
-
- Close
- A critical assessment on the role of sentinel node mapping in endometrial cancer
-
Bogani G, Ditto A, Martinelli F, Signorelli M, Perotto S, Lorusso D, Raspagliesi F
- KMID: 2345914
- J Gynecol Oncol.
- 2015 Oct;26(4):252-254.
- doi: 10.3802/jgo.2015.26.4.252
Endometrial cancer is the most common gynecologic malignancy in the developed countries. Although the high incidence of this occurrence no consensus, about the role of retroperitoneal staging, still exists. Growing... -
- CITED
-
- Close
- SHARE
-
- Close
- Current landscape and future perspective of sentinel node mapping in endometrial cancer
-
Bogani G, Raspagliesi F, Leone Roberti Maggiore U, Mariani A
- KMID: 2431239
- J Gynecol Oncol.
- 2018 Nov;29(6):e94.
- doi: 10.3802/jgo.2018.29.e94
Endometrial cancer (EC) represents the most common gynecological neoplasm in developed countries. Surgery is the mainstay of treatment for EC. Although EC is characterized by a high prevalence several features... -
- CITED
-
- Close
- SHARE
-
- Close
- Gynecologic oncology at the time of COVID-19 outbreak
-
Bogani G, Brusadelli C, Guerrisi R, Lopez S, Signorelli M, Ditto A, Raspagliesi F
- KMID: 2511971
- J Gynecol Oncol.
- 2020 Jul;31(4):e72.
- doi: 10.3802/jgo.2020.31.e72
The World Health Organization (WHO) classified the novel coronavirus (i.e., coronavirus disease 2019 [COVID-19]) as a global public health emergency. COVID-19 threatens to curtail patient access to evidence-based treatment. Medicine... -
- CITED
-
- Close
- SHARE
-
- Close
- A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
-
Bogani G, Tagliabue , Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci , Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2409941
- J Gynecol Oncol.
- 2018 May;29(3):e40.
- doi: 10.3802/jgo.2018.29.e40
OBJECTIVE: To test the applicability of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Memorial Sloan Kettering (MSK) criteria in predicting complete cytoreduction (CC) in patients undergoing secondary cytoreductive surgery (SCS) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women
-
Bogani G, Pinelli C, Chiappa V, Martinelli F, Lopez S, Ditto A, Raspagliesi F
- KMID: 2511973
- J Gynecol Oncol.
- 2020 Sep;31(5):e60.
- doi: 10.3802/jgo.2020.31.e60
Objective: This study aimed to identify predictors of recurrence/persistence of cervical intraepithelial neoplasia grade 2+ (CIN2+) lesion (r-CIN2+) after primary conization. Methods: Retrospective analysis involving all consecutive women having conization for... -
- CITED
-
- Close
- SHARE
-
- Close
- Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery
-
Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Leone C, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2457139
- J Gynecol Oncol.
- 2019 Mar;30(2):e27.
- doi: 10.3802/jgo.2019.30.e27
OBJECTIVES: Nerve-sparing radical hysterectomy has been implemented in order to reduce pelvic floor dysfunctions in women undergoing radical surgery for cervical cancer. Here, we aimed to investigate if the adoption... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer
-
Ditto A, Bogani G, Leone Roberti Maggiore U, Martinelli F, Chiappa V, Lopez C, Perotto S, Lorusso D, Raspagliesi F
- KMID: 2409942
- J Gynecol Oncol.
- 2018 May;29(3):e41.
- doi: 10.3802/jgo.2018.29.e41
OBJECTIVE: Nerve-sparing radical hysterectomy (NSRH) was introduced with the aim to reduce pelvic dysfunctions related to conventional radical hysterectomy (RH). Here, we sought to assess the effectiveness and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
-
Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Mosca L, Leone Roberti Maggiore U, Ferla S, Lorusso D, Raspagliesi F
- KMID: 2417462
- J Gynecol Oncol.
- 2018 Sep;29(5):e66.
- doi: 10.3802/jgo.2018.29.e66
OBJECTIVE: Accumulating evidence support that complete cytoreduction (CC) at the time of secondary cytoreductive surgery (SCS) improves survival in patients affected by recurrent ovarian cancer (ROC). Here, we aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
-
Indini A, Di Guardo , Cimminiello C, Lorusso D, Raspagliesi F, Del Vecchio M
- KMID: 2458899
- J Gynecol Oncol.
- 2019 Nov;30(6):e94.
- doi: 10.3802/jgo.2019.30.e94
OBJECTIVE: immunotherapy with immune checkpoint inhibitors has become one of the standard therapeutic modalities for patients with advanced melanoma. Melanoma of the female lower genital tract is a rare and... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia
-
Bogani G, Ditto A, Ferla S, Paolini B, Lombardo C, Lorusso D, Raspagliesi F
- KMID: 2457133
- J Gynecol Oncol.
- 2019 Mar;30(2):e20.
- doi: 10.3802/jgo.2019.30.e20
OBJECTIVE: We have investigated outcomes of women presenting with recurrent high-grade vaginal intra-epithelial neoplasia. METHODS: Data of consecutive women diagnosed with recurrent high-grade vaginal intra-epithelial neoplasia after primary treatment(s) were retrieved.... -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility sparing surgery in early stage epithelial ovarian cancer
-
Ditto A, Martinelli F, Lorusso D, Haeusler E, Carcangiu , Raspagliesi F
- KMID: 2130121
- J Gynecol Oncol.
- 2014 Oct;25(4):320-327.
- doi: 10.3802/jgo.2014.25.4.320
OBJECTIVE: Fertility sparing surgery (FSS) is a strategy often considered in young patients with early epithelial ovarian cancer. We investigated the role and the outcomes of FSS in eEOC patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
-
Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F
- KMID: 2450236
- J Gynecol Oncol.
- 2019 Jul;30(4):e57.
- doi: 10.3802/jgo.2019.30.e57
OBJECTIVE: To investigate the efficacy of levonorgestrel-releasing intra-uterine system (LNG-IUS) treatment in patients affected by atypical complex hyperplasia/endometrial cancer (ACH/EC) wishing to preserve their fertility and to present fertility outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
-
Bogani G, Leone Roberti Maggiore U, Paolini B, Diito A, Martinelli F, Lorusso D, Raspagliesi F
- KMID: 2429573
- J Gynecol Oncol.
- 2019 Jan;30(1):e4.
- doi: 10.3802/jgo.2019.30.e4
OBJECTIVE: To examine outcomes of patients having treatments for newly diagnosed advanced stage low-grade serous ovarian cancer (LGSC). METHODS: We conducted a retrospective case series of women affected by advanced stage... -
- CITED
-
- Close
- SHARE
-
- Close
